Orotracheal treprostinil administration attenuates bleomycin‐induced lung injury, vascular remodeling, and fibrosis in mice-Reference-Cited by-同舟云学术

Orotracheal treprostinil administration attenuates bleomycin‐induced lung injury, vascular remodeling, and fibrosis in mice

Published:2019-10 Issue:4 Volume:9 Page:1-14
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Nikitopoulou Ioanna¹,Manitsopoulos Nikolaos¹,Kotanidou Anastasia¹²,Tian Xia³,Petrovic Aleksandar³,Magkou Christina⁴,Ninou Ioanna⁵,Aidinis Vassilis⁵,Schermuly Ralph T.³,Kosanovic Djuro³⁶,Orfanos Stylianos E.¹²⁷

Affiliation:

1. GP Livanos and M Simou Laboratories1st Department of Critical Care & Pulmonary ServicesMedical SchoolNational & Kapodistrian University of AthensEvangelismos HospitalAthensGreece

2. 1st Department of Critical Care & Pulmonary ServicesMedical SchoolNational & Kapodistrian University of AthensEvangelismos HospitalAthensGreece

3. Universities of Giessen and Marburg Lung CenterMember of the German Center for Lung Research (DZL)Justus‐Liebig UniversityGiessenGermany

4. Department of PathologyEvangelismos HospitalAthensGreece

5. Institute of ImmunologyBiomedical Sciences Research Center Alexander FlemingAthensGreece

6. Sechenov First Moscow State Medical University (Sechenov University)MoscowRussia

7. 2nd Department of Critical CareMedical SchoolNational & Kapodistrian University of Athens“Attikon” HospitalHaidariAthensGreece

Funder

United Therapeutics Corporation

Galenica-Ferrer

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019881954

Reference61 articles.

1. Diagnostic and prognostic challenges in Idiopathic pulmonary fibrosis: a patient's “Q and A” approach;Tzouvelekis A;Pulm Pharmacol Ther,2017

2. Idiopathic pulmonary fibrosis: treatment and prognosis;Fujimoto H;Clin Med Insights Circul Respir Pulm Med,2015

3. A Systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis;Betensley A;J Clin Med,2016

4. Pulmonary hypertension in chronic lung disease and hypoxia;Nathan SD;Eur Respir J,2019

5. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi L;N Engl J Med,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

2. Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials;Expert Opinion on Emerging Drugs;2024-04-02

3. The vascular perspective on acute and chronic lung disease;Journal of Clinical Investigation;2023-08-15

4. The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?;American Journal of Physiology-Cell Physiology;2023-07-01

5. Idiopathic Pulmonary Fibrosis: 8 Years On After Nintedanib and Pirfenidone Approval—What Is on the Horizon?;Current Pulmonology Reports;2023-06-20